Susquehanna International Group, LLP Aim Immuno Tech Inc. Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$0.33 - $0.48 $537 - $781	1,629 Added 10.72%	16,830 $7,000
Q4 2023 Feb 14, 2024	BUY	$0.4 - $0.56 $6,080 - $8,512	15,201 New	15,201 $6,000
Q2 2023 Aug 11, 2023	BUY	$0.4 - $0.67 $17,840 - $29,882	44,601 Added 445.48%	54,613 $36,000
Q1 2023 May 16, 2023	SELL	$0.32 - $0.77 $7,687 - $18,496	-24,022 Reduced 70.58%	10,012 $4,000
Q4 2022 Feb 14, 2023	BUY	$0.31 - $0.6 $1,566 - $3,031	5,053 Added 17.44%	34,034 $10,000
Q3 2022 Nov 14, 2022	BUY	$0.57 - $0.81 $5,649 - $8,027	9,911 Added 51.97%	28,981 $17,000
Q2 2022 Aug 15, 2022	BUY	$0.78 - $1.27 $14,874 - $24,218	19,070 New	19,070 $15,000
Q1 2022 May 16, 2022	SELL	$0.67 - $1.18 $25,334 - $44,618	-37,812 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.92 - $1.96 $1,529 - $3,259	1,663 Added 4.6%	37,812 $35,000
Q3 2021 Nov 15, 2021	BUY	$1.91 - $2.17 $69,044 - $78,443	36,149 New	36,149 $73,000
Q3 2020 Nov 16, 2020	SELL	$1.77 - $3.88 $44,703 - $97,993	-25,256 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.9 - $2.94 $47,986 - $74,252	25,256 New	25,256 $63,000

9.01M

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $9.61M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.